BiotechTubeBiotechTube
Home/Cytovation/Lars Prestegarden
LP

Lars Prestegarden

Co-founder and Chief Executive Officer

Cytovation

Therapeutic Areas

OncologyImmunotherapy

Cytovation Pipeline

DrugIndicationPhase
CY-101Adrenocortical CarcinomaPhase 2
CY-101 + PembrolizumabColorectal CancerPhase 1/2

Leadership Team at Cytovation

FG
Federico Grego
Chief Operating Officer and Chief Financial Officer
DC
Diane Cowie
Head of CMC
View full Cytovation profile